НоваМедика / NovaMedica
Alexey Karpov is an experienced HR professional who has held various HR leadership roles in companies such as НоваМедика, GLS Pharmaceuticals, and OOO "NPF" Materia Medica Holding. With extensive experience in talent management, organizational development, and recruitment, Karpov has successfully implemented HR strategies that have led to increased efficiency, growth in headcount, and improved employee engagement. Karpov holds a PhD in Psychology and an EMBA in Business Administration and Management.
This person is not in the org chart
This person is not in any teams
НоваМедика / NovaMedica
NovaMedica is a modern Russian pharmaceutical company established in 2012. NovaMedica’s strategy is aimed at search and localization in Russia of innovative pharmaceutical products and creation of new drugs under its own R&D program. NovaMedica actively builds and expands a portfolio of CNS products, which is formed by its own developments. The Company has created the most suitable infrastructure for commercialization and promotion of both its own and partners’ drugs. In 2022, the Company received a certificate of conformity to the GOST R ISO 9001-2015 standard for its quality management system regarding wholesale trade in drug products for human use, including storage and transportation. In 2017, NovaMedica opened in Moscow the R&D Center NovaMedica Innotech (100% subsidiary of NovaMedica). The Center has state-of-the-art technological capacities, carries out research, development and manufacturing of innovative and effective drug products, including on a contractual basis. Innotech is GMP-compliant and has been issued a GMP _______________________ НоваМедика - современная российская фармацевтическая компания, созданная в 2012 году. Стратегия НоваМедики направлена на привлечение в Россию прав интеллектуальной собственности на инновационные препараты и технологии, на собственную разработку и вывод на рынок новых лекарств, а также на реализацию проектов на контрактной основе для партнеров, включая производство в полном соответствии со стандартами GMP. В 2017 года НоваМедика открыла R&D-центр «НоваМедика Иннотех», который даёт фармацевтам и исследователям новейшие технологические возможности, которые ранее были недоступны в российской фармацевтической индустрии. НоваМедика работает над созданием ряда собственных препаратов, которые находятся на разных стадиях развития: от создания лекарственной формы до клинических исследований, государственной регистрации и вывода на рынок. Историю нашего развития можно посмотреть здесь: http://novamedica.com/ru/about/history